LOGYNON Coated Tablets

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

LEVONORGESTREL, ETHINYLESTRADIOL, LEVONORGESTREL, ETHINYLESTRADIOL, LEVONORGESTREL, ETHINYLESTRADIOL

Available from:

Clear Pharma Limited

ATC code:

G03AB03

INN (International Name):

LEVONORGESTREL, ETHINYLESTRADIOL, LEVONORGESTREL, ETHINYLESTRADIOL, LEVONORGESTREL, ETHINYLESTRADIOL

Pharmaceutical form:

Coated Tablets

Prescription type:

Product subject to prescription which may be renewed (B)

Therapeutic area:

Progestogens and estrogens, sequential preparations

Authorization status:

Authorised

Authorization date:

2014-03-14

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER 
LOGYNON® TABLETS 
levonorgestrel and ethinylestradiol 
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TAKING THIS MEDICINE. 
• Keep this leaflet. You may need to read it again.
• If you
have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed
for you. Do not pass it on to others. It
may harm them, even if their symptoms are the same as yours.
• If any of the side effects gets serious, or if you
notice any side effects
not listed in this leaflet, please tell your doctor or pharmacist.
IN THIS LEAFLET: 
1. What Logynon is and what it is used for
2. Before you take Logynon
3. How to take Logynon
4. Possible side effects
5. How to store Logynon
6. Further information
1. WHAT LOGYNON IS AND WHAT IT IS USED FOR
• Logynon is a contraceptive pill and
is used to prevent pregnancy.
• Each tablet contains a small amount of two
different female hormones,
namely levonorgestrel and ethinylestradiol.
• Contraceptive pills that contain two hormones are called
‘combined’ pills.
2. BEFORE YOU TAKE LOGYNON
GENERAL NOTES 
Before you can begin taking Logynon, your doctor will ask you
some 
questions about your personal health history and
that of your close 
relatives. The doctor will also
measure your blood pressure, and 
depending upon your personal situation, may also
carry out some other 
tests for example a
breast exam or cervical screen as appropriate. 
In this leaflet, several situations are described where you
should stop 
using Logynon, or where the reliability of Logynon
may be decreased. 
In such situations you should either not have sex or you should
take 
extra non-hormonal contraceptive precautions, e.g., use a
condom or 
another barrier method. Do
not use rhythm or temperature methods. 
These

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Logynon Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH LIGHT BROWN TABLET CONTAINS:
Ethinylestradiol
30 micrograms
Levonorgestrel
50 micrograms
EACH WHITE TABLET CONTAINS:
Ethinylestradiol
40 micrograms
Levonorgestrel
75 micrograms
EACH OCHRE-COLOURED TABLET CONTAINS:
Ethinylestradiol
30 micrograms
Levonorgestrel
125 micrograms
Excipients: Each tablet also contains lactose and sucrose.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Coated tablet.
_Product imported from the UK:_
Each calendar-blister contains 6 light brown sugar-coated tablets, 5 white sugar-coated tablets and 10 ochre-coloured
sugar-coated tablets.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Oral contraception
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_METHOD OF ADMINISTRATION_
Oral use
_DOSAGE REGIMEN_
_How to take Logynon_
Combined oral contraceptives, when taken correctly, have a failure rate of approximately 1% per year. The failure rate
may increase when pills are missed or taken incorrectly.
The memo-pack contains 21 tablets. Tablet-taking is always started from the section marked “Start” and then continued
daily in the direction of the arrows.
Tablets must be taken in the order directed on the package every day at about the same time with some liquid as
needed.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 19/03/2014_
_CRN 2135495_
_page number: 1_
One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-free
interval, during which time a withdrawal bleed usually occurs.
This usually starts on day 2-3 after the last coated tablet and may not have finished before the next pack